Reactivity and amplification efficiency of the NASBA HIV-1 RNA amplification system with regard to different HIV-1 subtypes. 1997

E Gobbers, and K Fransen, and T Oosterlaken, and W Janssens, and L Heyndrickx, and T Ivens, and K Vereecken, and R Schoones, and P van de Wiel, and G van der Groen
Organon Teknika, Turnhout, Belgium.

In view of the genetic diversity of the human immunodeficiency virus Type 1, we assessed the sensitivity and quantification efficiency of the HIV-1 RNA NASBA amplification system with respect to different HIV-1 subtypes and recombinants. Twenty cell culture supernatants representing 17 HIV-1 group M and 3 group O strains were tested, and NASBA RNA loads were compared with results obtained with a RT-PCR based HIV-1 RNA quantitation method, with p24-antigen concentrations and with the infective dose. The current HIV-1 RNA NASBA seemed suitable to quantitate representatives of different HIV-1 M subtypes. Differences between NASBA and RT-PCR loads were observed for certain HIV-1 M strains. Significantly lower RT-PCR loads were measured for most gag A, gag B and gag F strains, whereas NASBA detected lower copy numbers in 1 gag H strain and 1 gag H/env G recombinant. NASBA was not able to quantify 1 HIV-1 group M recombinant. Some of these differences could be explained by the presence and position of mismatches with primers. HIV-1 group O strains were not detectable by both RNA amplification methods. A firm correlation was not observed between the measured RNA loads and either the p24-antigen concentration or the infective dose.

UI MeSH Term Description Entries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012367 RNA, Viral Ribonucleic acid that makes up the genetic material of viruses. Viral RNA
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity
D015203 Reproducibility of Results The statistical reproducibility of measurements (often in a clinical context), including the testing of instrumentation or techniques to obtain reproducible results. The concept includes reproducibility of physiological measurements, which may be used to develop rules to assess probability or prognosis, or response to a stimulus; reproducibility of occurrence of a condition; and reproducibility of experimental results. Reliability and Validity,Reliability of Result,Reproducibility Of Result,Reproducibility of Finding,Validity of Result,Validity of Results,Face Validity,Reliability (Epidemiology),Reliability of Results,Reproducibility of Findings,Test-Retest Reliability,Validity (Epidemiology),Finding Reproducibilities,Finding Reproducibility,Of Result, Reproducibility,Of Results, Reproducibility,Reliabilities, Test-Retest,Reliability, Test-Retest,Result Reliabilities,Result Reliability,Result Validities,Result Validity,Result, Reproducibility Of,Results, Reproducibility Of,Test Retest Reliability,Validity and Reliability,Validity, Face
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D019562 Viral Load The quantity of measurable virus in a body fluid. Change in viral load, measured in plasma, is sometimes used as a SURROGATE MARKER in disease progression. Viral Burden,Virus Titer,Burden, Viral,Load, Viral,Titer, Virus
D021141 Nucleic Acid Amplification Techniques Laboratory techniques that involve the in-vitro synthesis of many copies of DNA or RNA from one original template. DNA Amplification Technic,DNA Amplification Technique,DNA Amplification Techniques,Nucleic Acid Amplification Technic,Nucleic Acid Amplification Technique,RNA Amplification Technic,RNA Amplification Technique,RNA Amplification Techniques,Amplification Technics, Nucleic Acid,Amplification Techniques, Nucleic Acid,DNA Amplification Technics,Nucleic Acid Amplification Technics,Nucleic Acid Amplification Test,Nucleic Acid Amplification Tests,RNA Amplification Technics,Technics, Nucleic Acid Amplification,Techniques, Nucleic Acid Amplification,Amplification Technic, DNA,Amplification Technic, RNA,Amplification Technics, DNA,Amplification Technics, RNA,Amplification Technique, DNA,Amplification Technique, RNA,Amplification Techniques, DNA,Amplification Techniques, RNA,Technic, DNA Amplification,Technic, RNA Amplification,Technics, DNA Amplification,Technics, RNA Amplification,Technique, DNA Amplification,Technique, RNA Amplification,Techniques, DNA Amplification,Techniques, RNA Amplification

Related Publications

E Gobbers, and K Fransen, and T Oosterlaken, and W Janssens, and L Heyndrickx, and T Ivens, and K Vereecken, and R Schoones, and P van de Wiel, and G van der Groen
March 1995, Journal of virological methods,
E Gobbers, and K Fransen, and T Oosterlaken, and W Janssens, and L Heyndrickx, and T Ivens, and K Vereecken, and R Schoones, and P van de Wiel, and G van der Groen
March 1995, Journal of virological methods,
E Gobbers, and K Fransen, and T Oosterlaken, and W Janssens, and L Heyndrickx, and T Ivens, and K Vereecken, and R Schoones, and P van de Wiel, and G van der Groen
August 1995, Journal of virological methods,
E Gobbers, and K Fransen, and T Oosterlaken, and W Janssens, and L Heyndrickx, and T Ivens, and K Vereecken, and R Schoones, and P van de Wiel, and G van der Groen
September 1997, Journal of virological methods,
E Gobbers, and K Fransen, and T Oosterlaken, and W Janssens, and L Heyndrickx, and T Ivens, and K Vereecken, and R Schoones, and P van de Wiel, and G van der Groen
October 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association,
E Gobbers, and K Fransen, and T Oosterlaken, and W Janssens, and L Heyndrickx, and T Ivens, and K Vereecken, and R Schoones, and P van de Wiel, and G van der Groen
September 1994, Journal of virological methods,
E Gobbers, and K Fransen, and T Oosterlaken, and W Janssens, and L Heyndrickx, and T Ivens, and K Vereecken, and R Schoones, and P van de Wiel, and G van der Groen
July 1993, Journal of virological methods,
E Gobbers, and K Fransen, and T Oosterlaken, and W Janssens, and L Heyndrickx, and T Ivens, and K Vereecken, and R Schoones, and P van de Wiel, and G van der Groen
February 1995, PCR methods and applications,
E Gobbers, and K Fransen, and T Oosterlaken, and W Janssens, and L Heyndrickx, and T Ivens, and K Vereecken, and R Schoones, and P van de Wiel, and G van der Groen
August 2006, Journal of virological methods,
E Gobbers, and K Fransen, and T Oosterlaken, and W Janssens, and L Heyndrickx, and T Ivens, and K Vereecken, and R Schoones, and P van de Wiel, and G van der Groen
December 1996, AIDS (London, England),
Copied contents to your clipboard!